96 related articles for article (PubMed ID: 28483635)
1. Crystal structure of tissue factor in complex with antibody 10H10 reveals the signaling epitope.
Teplyakov A; Obmolova G; Malia TJ; Wu B; Zhao Y; Taudte S; Anderson GM; Gilliland GL
Cell Signal; 2017 Aug; 36():139-144. PubMed ID: 28483635
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tissue factor signaling suppresses tumor growth.
Versteeg HH; Schaffner F; Kerver M; Petersen HH; Ahamed J; Felding-Habermann B; Takada Y; Mueller BM; Ruf W
Blood; 2008 Jan; 111(1):190-9. PubMed ID: 17901245
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of a humanized Fab fragment of anti-tissue-factor antibody in complex with tissue factor.
Ohto U; Mizutani R; Nakamura M; Adachi H; Satow Y
J Synchrotron Radiat; 2004 Jan; 11(Pt 1):105-8. PubMed ID: 14646147
[TBL] [Abstract][Full Text] [Related]
4. Immunological and functional analyses of the extracellular domain of human tissue factor.
Magdolen V; Albrecht S; Kotzsch M; Haller C; Bürgle M; Jacob U; Grosser M; Kessler H; Graeff H; Müller M; Schmitt M; Luther T
Biol Chem; 1998 Feb; 379(2):157-65. PubMed ID: 9524067
[TBL] [Abstract][Full Text] [Related]
5. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
Norledge BV; Petrovan RJ; Ruf W; Olson AJ
Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of an inhibitory antibody on TF-initiated blood coagulation revealed by the crystal structures of human tissue factor, Fab 5G9 and TF.G9 complex.
Huang M; Syed R; Stura EA; Stone MJ; Stefanko RS; Ruf W; Edgington TS; Wilson IA
J Mol Biol; 1998 Feb; 275(5):873-94. PubMed ID: 9480775
[TBL] [Abstract][Full Text] [Related]
7. The 1.85 A resolution crystal structures of tissue factor in complex with humanized Fab D3h44 and of free humanized Fab D3h44: revisiting the solvation of antigen combining sites.
Faelber K; Kirchhofer D; Presta L; Kelley RF; Muller YA
J Mol Biol; 2001 Oct; 313(1):83-97. PubMed ID: 11601848
[TBL] [Abstract][Full Text] [Related]
8. Cross-talk of integrin alpha3beta1 and tissue factor in cell migration.
Dorfleutner A; Hintermann E; Tarui T; Takada Y; Ruf W
Mol Biol Cell; 2004 Oct; 15(10):4416-25. PubMed ID: 15254262
[TBL] [Abstract][Full Text] [Related]
9. Influence of cofactor binding and active site occupancy on the conformation of the macromolecular substrate exosite of factor VIIa.
Dickinson CD; Shobe J; Ruf W
J Mol Biol; 1998 Apr; 277(4):959-71. PubMed ID: 9545384
[TBL] [Abstract][Full Text] [Related]
10. Disulfide isomerization switches tissue factor from coagulation to cell signaling.
Ahamed J; Versteeg HH; Kerver M; Chen VM; Mueller BM; Hogg PJ; Ruf W
Proc Natl Acad Sci U S A; 2006 Sep; 103(38):13932-7. PubMed ID: 16959886
[TBL] [Abstract][Full Text] [Related]
11. Epitope location on tissue factor determines the anticoagulant potency of monoclonal anti-tissue factor antibodies.
Kirchhofer D; Moran P; Chiang N; Kim J; Riederer MA; Eigenbrot C; Kelley RF
Thromb Haemost; 2000 Dec; 84(6):1072-81. PubMed ID: 11154116
[TBL] [Abstract][Full Text] [Related]
12. Antibody mapping of tissue factor implicates two different exon-encoded regions in function.
Ruf W; Rehemtulla A; Edgington TS
Biochem J; 1991 Sep; 278 ( Pt 3)(Pt 3):729-33. PubMed ID: 1716883
[TBL] [Abstract][Full Text] [Related]
13. The effect of O-fucosylation on the first EGF-like domain from human blood coagulation factor VII.
Kao YH; Lee GF; Wang Y; Starovasnik MA; Kelley RF; Spellman MW; Lerner L
Biochemistry; 1999 Jun; 38(22):7097-110. PubMed ID: 10353820
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of active site-inhibited human coagulation factor VIIa (des-Gla).
Kemball-Cook G; Johnson DJ; Tuddenham EG; Harlos K
J Struct Biol; 1999 Oct; 127(3):213-23. PubMed ID: 10544046
[TBL] [Abstract][Full Text] [Related]
15. Predicted solution structure of zymogen human coagulation FVII.
Perera L; Darden TA; Pedersen LG
J Comput Chem; 2002 Jan; 23(1):35-47. PubMed ID: 11913388
[TBL] [Abstract][Full Text] [Related]
16. A novel anti-tissue factor monoclonal antibody with anticoagulant potency derived from synthesized multiple antigenic peptide through blocking FX combination with TF.
Peng ZC; Cai X; Zhang YG; Kong DS; Guo HS; Liang W; Tang QQ; Song HY; Ma D
Thromb Res; 2007; 121(1):85-93. PubMed ID: 17573098
[TBL] [Abstract][Full Text] [Related]
17. Epitope map for a growth hormone receptor agonist monoclonal antibody, MAb 263.
Wan Y; Zheng YZ; Harris JM; Brown R; Waters MJ
Mol Endocrinol; 2003 Nov; 17(11):2240-50. PubMed ID: 12907759
[TBL] [Abstract][Full Text] [Related]
18. Differential ability of tissue factor antibody clones on detection of tissue factor in blood cells and microparticles.
Basavaraj MG; Olsen JO; Østerud B; Hansen JB
Thromb Res; 2012 Sep; 130(3):538-46. PubMed ID: 22728024
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of tissue factor/protease-activated receptor-2 signaling limits proliferation, migration and invasion of malignant glioma cells.
Gessler F; Voss V; Dützmann S; Seifert V; Gerlach R; Kögel D
Neuroscience; 2010 Feb; 165(4):1312-22. PubMed ID: 19958818
[TBL] [Abstract][Full Text] [Related]
20. Structural insights into the extracellular recognition of the human serotonin 2B receptor by an antibody.
Ishchenko A; Wacker D; Kapoor M; Zhang A; Han GW; Basu S; Patel N; Messerschmidt M; Weierstall U; Liu W; Katritch V; Roth BL; Stevens RC; Cherezov V
Proc Natl Acad Sci U S A; 2017 Aug; 114(31):8223-8228. PubMed ID: 28716900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
